Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-,sodium salt (1:1)

상품명칭:	Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-,sodium salt (1:1)
CAS 레지스트리 번호:	1476-53-5
EINECS:	216-023-6
동의어:	Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-,sodium salt (1:1);Benzamide,N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-a-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl)-,monosodium salt (9CI); Novobiocin, monosodium salt (8CI); Cathomycinsodium; Albamycin (capsule); Sodiumnovobiocin; Novobiocin sodium; Vulcamycin; NSC 2382; Novobiocin sodium salt; Albamycin; Sodium albamycin; Novobiocinmonosodium; Albamycin sodium; Cathomycin sodium lyovac; Monosodium novobiocin; Novobiocin, sodiumderiv. (6CI,7CI);
분자 구조:
분자식:	C31H35N2NaO11
분자량:	634.61
밀도:	1.42g/cm³
비등점:	848.2°Cat760mmHg
녹는점:	215-220 C
인화점:	466.8°C
위험 코드:	43-36
안전 문장:	Poison by intraperitoneal and subcutaneous routes. Moderately toxic by ingestion. Mutation data reported. An antibiotic with serious side effects which include liver and blood disease. It may also promote the development of resistant strains of staphylococcus. When heated to decomposition it emits toxic fumes of NOx and Na2O.
위험 기호:	Xi: Irritant;

기타 제품